The challenge of using SNPs in the understanding and treatment of disease.
Schifreen
Richard S
RS
Promega Corporation, Madison, WI 53711, USA. rschifre@promega.com
Storts
Douglas R
DR
Buller
Arlene M
AM
D011125:Adenomatous Polyposis Coli / Q000175:diagnosis / Q000235:genetics; D001331:Automation / Q000295:instrumentation / Q000379:methods; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D004252:DNA Mutational Analysis / Q000295:instrumentation / Q000379:methods; D030561:Databases, Nucleic Acid; D005260:Female; D005787:Gene Frequency; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005828:Genetics, Population; D015894:Genome, Human; D006239:Haplotypes; D006801:Humans; D020412:Multifactorial Inheritance; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000235:genetics; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D019851:Thrombophilia
D005819:Genetic Markers